-
Company Insights
Innovation and Patenting activity of Dong Wha Pharma Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Dong Wha Pharma Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decitabine in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Decitabine in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Decitabine in Metastatic Breast Cancer Drug Details: Decitabine (DW-1018) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decitabine in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Decitabine in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Decitabine in...
-
Product Insights
Duodenal Ulcer – Drugs In Development, 2023
Global Markets Direct’s, ‘Duodenal Ulcer - Drugs In Development, 2023’, provides an overview of the Duodenal Ulcer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Duodenal Ulcer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Gastric Ulcers – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastric Ulcers - Drugs In Development, 2023’, provides an overview of the Gastric Ulcers pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastric Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Acute Coronary Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Coronary Syndrome - Drugs In Development, 2023’, provides an overview of the Acute Coronary Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Coronary Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Sarcopenia – Drugs In Development, 2023
Global Markets Direct’s, ‘Sarcopenia - Drugs In Development, 2023’, provides an overview of the Sarcopenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Peptic Ulcers – Drugs In Development, 2023
Global Markets Direct’s, ‘Peptic Ulcers - Drugs In Development, 2023’, provides an overview of the Peptic Ulcers pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peptic Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...